IP Library Granted Patent US 9,309,432
Granted Patent B1
US 9,309,432 · App. 13/772,632 · Granted Apr 12, 2016

Polyethylene glycol based oligomers for coating nanoparticles, nanoparticles coated therewith, and related methods

Inventors: Hedi Mattoussi (Tallahassee, FL); Goutam Palui (Tallahassee, FL); Hyon Bin Na (Tallahassee, FL)
Assignee: The Florida State University Research Foundation, Inc.
C09D133/02C08F20/06C08F22/00C08F118/02C08F220/26C08L33/00C08K3/18C08K5/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,432
App. No.
13/772,632
Granted
Apr 12, 2016
Kind
B1
Abstract

In a composition aspect of the invention, a nanoparticle coating comprises repeating polyacrylic acid monomers covalently bound together in an aliphatic chain having a plurality of carboxylic acid functional groups and modified carboxylic acid functional groups extending therefrom. A first portion of the modified carboxylic acid functional groups are modified by a PEG oligomer having a terminal methoxy functional group and a second portion of the modified carboxylic acid functional groups are modified by a PEG oligomer having at least one terminal catechol group.

Claims (5)

1. A composition comprising repeating polyacrylic acid monomer units covalently bound together in an aliphatic chain having a plurality of carboxylic acid functional groups and modified carboxylic acid functional groups extending therefrom, wherein a first portion of the modified carboxylic acid functional groups are modified by a PEG oligomer having a terminal methoxy functional group and a second portion of the modified carboxylic acid functional groups are modified by a PEG oligomer having at least one terminal catechol group.

2. The composition of claim 1 , wherein the PEG oligomer having a terminal methoxy functional group comprises a PEG chain having a terminal amine group opposite the terminal methoxy functional group, the terminal amine group being covalently bound to a carbonyl carbon of a modified carboxylic acid functional group.

3. The composition of claim 1 , wherein the PEG oligomer having at least one terminal catechol group is dopamine.

4. The composition of claim 1 , further comprising a third portion of modified carboxylic acid functional groups wherein the third portion of the modified carboxylic acid functional groups are modified by a PEG oligomer having functional group.

5. The composition of claim 1 , wherein the number of polyacrylic acid monomer units is between about 20 to about 30.

Assignments (3)
CONFIRMATORY LICENSE Recorded Apr 11, 2016
From: FLORIDA STATE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 038401/0460 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNORS LAST NAME PREVIOUSLY RECORDED ON REEL 031581 FRAME 0153. ASSIGNOR(S) HEREBY CONFIRMS THE MATTOUSI SHOULD BE SPELLED MATTOUSSI AND PAULI SHOULD BE SPELLED PALUI. Recorded Jul 7, 2015
From: MATTOUSSI, HEDI; PALUI, GOUTAM; NA, HYON BIN
To: THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Reel/Frame 036073/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2013
From: MATTOUSI, HEDI; NA, HYON BIN; PAULI, GOUTAM
To: THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Reel/Frame 031581/0153 →
Continuity (2)
Continuation In Part 13608119 · Sep 10, 2012
Provisional Application 61532756 · Sep 9, 2011